Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Net Current Assets

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹5,218 Cr₹4,247 Cr₹6,172 Cr₹5,270 Cr₹4,611 Cr

What is the latest Net Current Assets ratio of GLAND PHARMA ?

The latest Net Current Assets ratio of GLAND PHARMA is ₹5,218 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹5,218 Cr
Mar2024₹4,247 Cr
Mar2023₹6,172 Cr
Mar2022₹5,270 Cr
Mar2021₹4,611 Cr

How is Net Current Assets of GLAND PHARMA Trending?

Years Net Current Assets % Change
Mar2025 ₹5,218 Cr
22.87
Mar2024 ₹4,247 Cr
-31.19
Mar2023 ₹6,172 Cr
17.11
Mar2022 ₹5,270 Cr
14.29
Mar2021 ₹4,611 Cr -

Compare Net Current Assets of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹38,176.1 Cr 5.3% 0.3% 36.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,792.0 Cr 1.4% 1.2% 13.8% Stock Analytics
DIVIS LABORATORIES ₹178,152.0 Cr -0.5% -0.6% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,915.0 Cr 2.1% 1.5% 42.2% Stock Analytics
CIPLA ₹116,354.0 Cr 6.4% 1.6% -3.1% Stock Analytics
DR REDDYS LABORATORIES ₹112,681.0 Cr 6.2% 1.6% 0.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

5.3%

0.3%

36.1%

SENSEX

-0.4%

0.8%

-5.3%


You may also like the below Video Courses